Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Total 13F shares
-
34,176,168
-
Share change
-
-1,948,422
-
Total reported value
-
$139,126,000
-
Put/Call ratio
-
44%
-
Price per share
-
$4.07
-
Number of holders
-
68
-
Value change
-
-$8,594,155
-
Number of buys
-
27
-
Number of sells
-
56
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q2 2022
As of 30 Jun 2022 Olema Pharmaceuticals, Inc. - Common Stock (OLMA) had 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,176,168 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Logos Global Management LP, JANUS HENDERSON GROUP PLC, Fairmount Funds Management LLC, Cormorant Asset Management, LP, Vivo Capital, LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., and MILLENNIUM MANAGEMENT LLC.
This table shows 69 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.